These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9795237)

  • 21. A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors.
    Ueda N; Goparaju SK; Katayama K; Kurahashi Y; Suzuki H; Yamamoto S
    J Med Invest; 1998 Aug; 45(1-4):27-36. PubMed ID: 9864962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cannabinoids, cannabinoid receptor and immune response].
    Yan MS; Lian ML; Huang JS
    Sheng Li Ke Xue Jin Zhan; 2000 Jul; 31(3):261-4. PubMed ID: 12545719
    [No Abstract]   [Full Text] [Related]  

  • 23. Cannabinoid ligand-receptor signaling in the mouse uterus.
    Das SK; Paria BC; Chakraborty I; Dey SK
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4332-6. PubMed ID: 7753807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
    Priller J; Briley EM; Mansouri J; Devane WA; Mackie K; Felder CC
    Mol Pharmacol; 1995 Aug; 48(2):288-92. PubMed ID: 7651362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anandamides: tolerance and cross-tolerance to delta 9-tetrahydrocannabinol.
    Fride E
    Brain Res; 1995 Oct; 697(1-2):83-90. PubMed ID: 8593598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling.
    Paria BC; Das SK; Dey SK
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9460-4. PubMed ID: 7568154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids.
    Di Marzo V; Bisogno T; De Petrocellis L; Melck D; Martin BR
    Curr Med Chem; 1999 Aug; 6(8):721-44. PubMed ID: 10469888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
    Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
    Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide.
    Wartmann M; Campbell D; Subramanian A; Burstein SH; Davis RJ
    FEBS Lett; 1995 Feb; 359(2-3):133-6. PubMed ID: 7867785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
    Solinas M; Scherma M; Tanda G; Wertheim CE; Fratta W; Goldberg SR
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1127-34. PubMed ID: 17351107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes.
    Rockwell CE; Kaminski NE
    J Pharmacol Exp Ther; 2004 Nov; 311(2):683-90. PubMed ID: 15284281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A biosynthetic pathway for anandamide.
    Liu J; Wang L; Harvey-White J; Osei-Hyiaman D; Razdan R; Gong Q; Chan AC; Zhou Z; Huang BX; Kim HY; Kunos G
    Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13345-50. PubMed ID: 16938887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Task specificity of cross-tolerance between Delta9-tetrahydrocannabinol and anandamide analogs in mice.
    Wiley JL; Smith FL; Razdan RK; Dewey WL
    Eur J Pharmacol; 2005 Mar; 510(1-2):59-68. PubMed ID: 15740725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
    Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
    Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction.
    Schuel H; Goldstein E; Mechoulam R; Zimmerman AM; Zimmerman S
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7678-82. PubMed ID: 8052642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids.
    Darmani NA
    J Pharmacol Exp Ther; 2002 Jan; 300(1):34-42. PubMed ID: 11752094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biosynthesis and turnover of anandamide and other N-acylethanolamines in peritoneal macrophages.
    Kuwae T; Shiota Y; Schmid PC; Krebsbach R; Schmid HH
    FEBS Lett; 1999 Oct; 459(1):123-7. PubMed ID: 10508930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans.
    Thieme U; Schelling G; Hauer D; Greif R; Dame T; Laubender RP; Bernhard W; Thieme D; Campolongo P; Theiler L
    Drug Test Anal; 2014; 6(1-2):17-23. PubMed ID: 24424856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
    Herradón E; Martín MI; López-Miranda V
    Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes.
    Devane WA; Axelrod J
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6698-701. PubMed ID: 8022836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.